In September 2024, Orbis announced a research collaboration with Vivtex to leverage its gastrointestinal robotic interface system (GI-ORIS), a platform designed to assess gut permeability ...

Quod Orbis platform Archer has been a pioneer in risk management for over 20 years, uniting stakeholders, integrating technologies, and shaping GRC and risk management solutions, helping organisations ...

About Orbis Medicines Orbis Medicines is pioneering a new era for oral macrocycle drug discovery. Its n Gen platform systematically delivers macrocycle candidates, termed n Cycles. These are ...

Kate Gannon, deputy director of programme funding at Orbis UK, told OT: “With our dedicated partners, we’re working to ensure no-one has to live with avoidable blindness.” ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Orbis Medicines, a European biotechnology startup, has raised 90 million euros, or about $93 million ...

Orbis Corp. is closing a reusable packaging manufacturing plant in Wisconsin, consolidating production into a new Texas site. The Oconomowoc, Wis.-based company indicated that a total of 109 ...

For Orbis Corp., one idea of success is getting closer to the company's customers — and in more ways than one. The maker of reusable packaging such as durable plastic pallets and totes is ...

Oconomowoc-based ORBIS Corp., a manufacturer of sustainable reusable packaging, will soon cease operations at its Menasha facility, according to a recently filed WARN notice. The Menasha plant ...

By harnessing the latest advances in AI, including fundamental vision models, TomTom Orbis Maps can now produce ... software across its entire fleet via Platform Science’s Virtual Vehicle ...

Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the close of a EUR 90 million Series A funding round, bringing the total amount raised by the company to EUR 116 ...